Literature DB >> 129438

Phage group II staphylococcal strains with chromosomal and extrachromosomal genes for exfoliative toxin production.

M Rogolsky, B B Wiley, L A Glasgow.   

Abstract

Staphylococcal phage group 2 strain UT0007 was previously shown to contain a high-molecular-weight plasmid containing genes for exfoliative toxin (ET) and bacteriocin production. Phage group 2 strains UT0002 and UT0003 (Tox+Bac-) underwent a twofold and ninefold loss of ET activity, respectively, after growth at 44 C for 18 h. Strain UT0002 also lost total bacteriocin activity. Both strains contained (i) a 56S plasmid that was lost from those substrains showing reduced ET activity and (ii) a 21S plasmid with a gene for cadmium resistance that could be transduced into two recipient strains. Since the ET plasmid-negative substrains still made ET, it was postulated that this residual toxin was made from chromosomal genes. In characterizing the plasmid species from strains UT0002 and UT0003, the 21S but little or no 56S plasmid deoxyribonucleic acid could be isolated after centrifugation of cleared lysates from these strains on dye-buoyant density gradients. Treatment of cleared lysates from strain UT0002 with ethidium bromide, Pronase, or sodium dodecyl sulfate, but not heat at 60 C, induced conversion of the 56S closed circular ET plasmid to a 38S open circular form as determined after centrifugation on 5 to 20% neutral sucrose gradients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 129438      PMCID: PMC420575          DOI: 10.1128/iai.13.1.44-52.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  Isolation of extrachromosomal deoxyribonucleic acid for exfoliative toxin production from phage group II Staphylococcus aureus.

Authors:  R Warren; M Rogolsky; B B Wiley; L A Glasgow
Journal:  J Bacteriol       Date:  1975-04       Impact factor: 3.490

2.  Properties of the relaxation complexes of supercoiled deoxyribonucleic acid and protein of the R plasmids R64, R28K, and R6K.

Authors:  Y M Kupersztoch-Portnoy; G L Miklos; D R Helinski
Journal:  J Bacteriol       Date:  1974-10       Impact factor: 3.490

3.  The staphylococcal scalded-skin syndrome: isolation and partial characterization of the exfoliative toxin.

Authors:  M E Melish; L A Glasgow; M D Turner
Journal:  J Infect Dis       Date:  1972-02       Impact factor: 5.226

4.  Nature of the genetic determinant controlling exfoliative toxin production in Staphylococcus aureus.

Authors:  M Rogolsky; R Warren; B B Wiley; H T Nakamura; L A Glasgow
Journal:  J Bacteriol       Date:  1974-01       Impact factor: 3.490

5.  Purification of exfoliatin produced by Staphylococcus aureus of bacteriophage group 2 and its physicochemical properties.

Authors:  I Kondo; S Sakurai; Y Sarai
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

6.  Staphylococcal scalded skin syndrome: the expanded clinical syndrome.

Authors:  M E Melish; L A Glasgow
Journal:  J Pediatr       Date:  1971-06       Impact factor: 4.406

7.  Effect of ethidium bromide on elimination of exfoliative toxin and bacteriocin production in Staphylococcus aureus.

Authors:  R Warren; M Rogolsky; B B Wiley; L A Glasgow
Journal:  J Bacteriol       Date:  1974-06       Impact factor: 3.490

8.  Nursery outbreak of staphylococcal scalded skin syndrome. Rapid identification of the epidemic bacterial strain.

Authors:  B F Anthony; D M Giuliano; W Oh
Journal:  Am J Dis Child       Date:  1972-07

9.  Supercoiled circular DNA-protein complex in Escherichia coli: purification and induced conversion to an opern circular DNA form.

Authors:  D B Clewell; D R Helinski
Journal:  Proc Natl Acad Sci U S A       Date:  1969-04       Impact factor: 11.205

10.  The problems of drug-resistant pathogenic bacteria. Extrachromosomal nature of drug resistance in Staphylococcus aureus.

Authors:  R P Novick; D Bouanchaud
Journal:  Ann N Y Acad Sci       Date:  1971-06-11       Impact factor: 5.691

  10 in total
  17 in total

1.  Method for quantitating sensitivity to a staphylococcal bacteriocin.

Authors:  G Van Norman; N Groman
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

2.  Effect of a staphylococcin on Neisseria gonorrhoeae.

Authors:  D M Morriss; J W Lawson; M Rogolsky
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

Review 3.  Nonenteric toxins of Staphylococcus aureus.

Authors:  M Rogolsky
Journal:  Microbiol Rev       Date:  1979-09

4.  Chromosomal determinants for exfoliative toxin production in two strains of staphylococci.

Authors:  E D Rosenblum; S Tyrone
Journal:  Infect Immun       Date:  1976-11       Impact factor: 3.441

5.  Production and properties of a staphylococcin genetically controlled by the staphylococcal plasmid for exfoliative toxin synthesis.

Authors:  M Rogolsky; B B Wiley
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

6.  Transfer of the plasmid for exfoliative toxin B synthesis in mixed cultures on nitrocellulose membranes.

Authors:  M Rogolsky; B W Beall; B B Wiley
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

7.  Purification and characterization of different types of exfoliative toxin from Staphylococcus aureus.

Authors:  A D Johnson; L Spero; J S Cades; B T de Cicco
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

8.  A circular-dichroism study of epidermolytic toxins A and B from Staphylococcus aureus.

Authors:  C J Bailey; S R Martin; P M Bayley
Journal:  Biochem J       Date:  1982-06-01       Impact factor: 3.857

9.  Exfoliative toxin plasmids of bacteriophage group 2 Staphylococcus aureus: sequence homology.

Authors:  R L Warren
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

10.  Mutagenesis of extrachromosomal genetic determinants for exfoliative toxin B and bacteriocin R1 synthesis in Staphylococcus aureus after plasmid transfer by protoplast fusion.

Authors:  R Masterson; W von David; B B Wiley; M Rogolsky
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.